Status:
COMPLETED
Long-term Effects of COVID-19
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
COVID-19
SAR-CoV-2
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to measure, monitor, and analyze long term effects of SARS-CoV-2. The main purpose is to assess the post-hospitalization outcomes of patients who were diagnosed with SAR-C...
Eligibility Criteria
Inclusion
- Control Participants: Males and females over the age of 18 years hospitalized and receiving intensive care for diagnosis's other than COVID-19 or an acute neurological disease and who were not diagnosed (clinically or with PCR testing) with COVID-19.
- Case Participants: Males and females over the age of 18 years who had been hospitalized at Mayo Clinic Hospital for treatment of COVID-19 confirmed by PCR test.
- We acknowledge that some participants may be unable to consent due to underlying medical conditions; an eligible proxy may provide the informed consent and provide a signature on the designated line.
- Women of childbearing age, between the ages of 18 to 55, must complete a negative pregnancy test.
- Minority individuals over the age of 18 years will be eligible to enroll.
Exclusion
- Males and females, under the age of 18 years.
- Participants with PET/MRI non-compatible devices.
- Claustrophobia.
- Allergies to study related procedures.
- Pregnant , incarcerated, or institutionalized subjects will not be included in the study.
Key Trial Info
Start Date :
January 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT05220514
Start Date
January 19 2022
End Date
November 30 2024
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Florida
Jacksonville, Florida, United States, 32224